Peer-reviewedCC BYInternational journal of molecular sciences
Combined SGLT-2 Inhibitor and Mineralocorticoid Receptor Antagonist Therapy: Effects on the Renin–Angiotensin–Aldosterone System in Heart Failure Treatment
- 1Department of Translational and Precision Medicine, University “Sapienza”, 00185 Rome, Italy;
- 2Department of Medical and Cardiovascular Sciences, University “Sapienza”, 00185 Rome, Italy; (L.C.G.); (G.C.); (F.C.); (T.C.L.); (C.L.)
Related
- Distinct conformational dynamics of the type-2 Angiotensin II receptor bound to Angiotensin II and Angiotensin (1–7)
- Structural Basis for Angiotensin II Type I Receptor G Protein-biased Signaling
- Angiotensin II-Induced Cardiac Fibrosis: Genomic and Molecular Drivers, Emerging Biomarkers and Therapeutic Perspectives
- Synthesis and focused structure-activity investigation of the BB3 receptor antagonist, Bantag-1
- Molecular Determinants of G Protein Subtype-Specific Coupling to the Angiotensin II Type 1 Receptor
BibTeX
@article{petramala2026combined,
title = {{Combined SGLT-2 Inhibitor and Mineralocorticoid Receptor Antagonist Therapy: Effects on the Renin–Angiotensin–Aldosterone System in Heart Failure Treatment}},
author = {Luigi Petramala and Luca Caprioni Grasso and Giuseppe Calise and Francesco Circosta and Tommaso Claudio Letizia and Luca Marino and Claudio Letizia},
journal = {International journal of molecular sciences},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13664944},
note = {CC BY},
}
RIS
TY - JOUR
TI - Combined SGLT-2 Inhibitor and Mineralocorticoid Receptor Antagonist Therapy: Effects on the Renin–Angiotensin–Aldosterone System in Heart Failure Treatment
AU - Luigi Petramala
AU - Luca Caprioni Grasso
AU - Giuseppe Calise
AU - Francesco Circosta
AU - Tommaso Claudio Letizia
AU - Luca Marino
AU - Claudio Letizia
PY - 2026
DA - 2026/09/24
JO - International journal of molecular sciences
UR - https://europepmc.org/article/PMC/PMC13664944
SN - 1422-0067
ER -